• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.预测在全州范围内的常备医嘱后,药房纳洛酮的库存和配药情况,印第安纳州,2016 年。
Drug Alcohol Depend. 2018 Jul 1;188:187-192. doi: 10.1016/j.drugalcdep.2018.03.032. Epub 2018 Apr 26.
2
Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order.在印第安纳州全州范围内实施常备处方 2 年后,纳洛酮在该州药店的供应和配给情况。
J Am Pharm Assoc (2003). 2020 May-Jun;60(3):470-474. doi: 10.1016/j.japh.2019.11.024. Epub 2020 Jan 6.
3
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.态度与可得性:阿拉巴马州农村和城市地区连锁和独立药店纳洛酮配给情况比较。
Int J Drug Policy. 2019 Dec;74:229-235. doi: 10.1016/j.drugpo.2019.09.021. Epub 2019 Nov 5.
4
Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.根据宾夕法尼亚州的常规医嘱,培训药剂师以增加社区药房内纳洛酮的配药量。
Am J Health Syst Pharm. 2021 Feb 8;78(4):327-335. doi: 10.1093/ajhp/zxaa387.
5
Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order.与密歇根州药店常备处方制度下纳洛酮可得性和配发相关的因素。
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):454-463. doi: 10.1080/00952990.2022.2047714. Epub 2022 Apr 11.
6
Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies.按常规医嘱配发纳洛酮时的药剂师咨询:对4家连锁药店的暗访研究
J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e94-e99. doi: 10.1016/j.japh.2020.10.010. Epub 2020 Nov 3.
7
Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.纳洛酮的可及性和宾夕法尼亚州药店中纳洛酮使用规定的药剂师知识。
J Addict Med. 2019 Jul/Aug;13(4):272-278. doi: 10.1097/ADM.0000000000000492.
8
Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.药剂师与纳洛酮:配药障碍及一项教育推广计划的成效
J Am Pharm Assoc (2003). 2023 Mar-Apr;63(2):608-613.e3. doi: 10.1016/j.japh.2022.12.018. Epub 2022 Dec 20.
9
Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.马萨诸塞州全州范围内纳洛酮待命医嘱计划中药剂师的经验:混合方法研究。
J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):157-166. doi: 10.1016/j.japh.2021.08.020. Epub 2021 Aug 23.
10
Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.识别纳洛酮配药的障碍:对北卡罗来纳州社区药剂师的一项调查。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S55-S58.e3. doi: 10.1016/j.japh.2018.04.025.

引用本文的文献

1
Naloxone training programs in corporately-owned versus independently-owned Alabama community pharmacies: A pilot cross-sectional survey.阿拉巴马州公司所有与独立经营的社区药房中的纳洛酮培训项目:一项试点横断面调查
Drug Alcohol Depend Rep. 2025 Mar 28;15:100326. doi: 10.1016/j.dadr.2025.100326. eCollection 2025 Jun.
2
Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities study.为药剂师开发一份简短的污名与认知调查问卷:在参与康复社区研究的纽约州各县采用探索性因素分析方法
J Subst Use Addict Treat. 2025 Feb;169:209566. doi: 10.1016/j.josat.2024.209566. Epub 2024 Nov 9.
3
A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California.一项关于加利福尼亚州药剂师准备提供长效注射型 HIV 暴露前预防的混合方法评估。
J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):142-149. doi: 10.1097/QAI.0000000000003470.
4
Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients.探究纳洛酮分发的复杂性:哪些政策对药店和潜在接受者重要。
J Health Econ. 2024 Sep;97:102917. doi: 10.1016/j.jhealeco.2024.102917. Epub 2024 Jul 17.
5
Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order.伊利诺伊州常备令下注册药店的纳洛酮可及性。
West J Emerg Med. 2024 Jul;25(4):457-464. doi: 10.5811/westjem.17979.
6
Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report.PharmNet干预措施的实施文档与过程评估:观察性报告
JMIR Form Res. 2024 Mar 18;8:e54077. doi: 10.2196/54077.
7
Come back when you're infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023.2023 年亚利桑那州秘密购物者研究:当您感染时再来:药房获得无菌注射器的机会。
Harm Reduct J. 2024 Feb 22;21(1):49. doi: 10.1186/s12954-024-00943-w.
8
"Like it was just everyday business": A qualitative study of pharmacy-based naloxone and syringe customer experience.“就像日常业务一样”:一项基于药房的纳洛酮和注射器顾客体验的定性研究。
J Am Pharm Assoc (2003). 2023 May-Jun;63(3):838-846. doi: 10.1016/j.japh.2023.01.013. Epub 2023 Jan 27.
9
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician.实施学术细化干预,以增加纳洛酮的发放,并促进社区临床医生参与减少伤害。
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):284-294.e1. doi: 10.1016/j.japh.2022.12.001. Epub 2022 Dec 7.
10
The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial.社区药房的PharmNet减少伤害干预措施:一项试点随机对照试验方案
JMIR Res Protoc. 2022 Oct 24;11(10):e42373. doi: 10.2196/42373.

本文引用的文献

1
Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.延续污名还是降低风险?来自两个州纳洛酮使用者和药剂师对基于药房的纳洛酮的看法。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S19-S27.e4. doi: 10.1016/j.japh.2017.01.013. Epub 2017 Feb 14.
2
Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.2015年马萨诸塞州阿片类药物过量和丙型肝炎病毒流行期间的非处方纳洛酮和注射器销售情况
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S34-S44. doi: 10.1016/j.japh.2016.12.077. Epub 2017 Feb 8.
3
Strategies and policies to address the opioid epidemic: A case study of Ohio.应对阿片类药物流行的策略与政策:以俄亥俄州为例
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S148-S153. doi: 10.1016/j.japh.2017.01.001. Epub 2017 Feb 8.
4
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.西弗吉尼亚州社区药房药剂师提供纳洛酮的意愿。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S12-S18.e4. doi: 10.1016/j.japh.2016.12.070. Epub 2017 Feb 2.
5
Detecting naloxone prejudices in the pharmacy setting.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S10-S11. doi: 10.1016/j.japh.2016.12.068. Epub 2017 Jan 31.
6
Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.药剂师在阿片类药物过量使用中的作用:肯塔基州药剂师参与纳洛酮配药的意愿。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S28-S33. doi: 10.1016/j.japh.2016.12.064. Epub 2017 Jan 28.
7
Against the Odds: Syringe Exchange Policy Implementation in Indiana.克服重重困难:印第安纳州注射器交换政策的实施
AIDS Behav. 2017 Apr;21(4):973-981. doi: 10.1007/s10461-017-1688-7.
8
State legal innovations to encourage naloxone dispensing.鼓励纳洛酮配发的州法律创新举措。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S180-S184. doi: 10.1016/j.japh.2016.11.007. Epub 2017 Jan 7.
9
The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.纳洛酮价格上涨——对遏制过量用药死亡努力的风险。
N Engl J Med. 2016 Dec 8;375(23):2213-2215. doi: 10.1056/NEJMp1609578.
10
Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.为什么实施变革如此困难?对安全网环境中用于预防药物过量的纳洛酮分发的障碍和促进因素进行定性研究。
BMC Res Notes. 2016 Oct 18;9(1):465. doi: 10.1186/s13104-016-2268-z.

预测在全州范围内的常备医嘱后,药房纳洛酮的库存和配药情况,印第安纳州,2016 年。

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.

机构信息

Indiana University School of Public Health-Bloomington, 1025 E. 7th St., Bloomington, IN 47405, USA; Rural Center for AIDS/STD Prevention, Indiana University, 801 E. 7th St., Bloomington, IN 47405, USA.

Indiana University School of Public Health-Bloomington, 1025 E. 7th St., Bloomington, IN 47405, USA; Indiana Prevention Research Center, Indiana University,501 N. Morton St. Suite 110, Bloomington, IN 47404, USA; Institute for Research on Addictive Behavior, Indiana University, 501 N. Morton St. Suite 104, Bloomington, IN 47404, USA.

出版信息

Drug Alcohol Depend. 2018 Jul 1;188:187-192. doi: 10.1016/j.drugalcdep.2018.03.032. Epub 2018 Apr 26.

DOI:10.1016/j.drugalcdep.2018.03.032
PMID:29778772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375076/
Abstract

BACKGROUND

While naloxone, the overdose reversal medication, has been available for decades, factors associated with its availability through pharmacies remain unclear. Studies suggest that policy and pharmacist beliefs may impact availability. Indiana passed a standing order law for naloxone in 2015 to increase access to naloxone.

OBJECTIVE

To identify factors associated with community pharmacy naloxone stocking and dispensing following the enactment of a statewide naloxone standing order.

METHODS

A 2016 cross-sectional census of Indiana community pharmacists was conducted following a naloxone standing order. Community, pharmacy, and pharmacist characteristics, and pharmacist attitudes about naloxone dispensing, access, and perceptions of the standing order were measured. Modified Poisson and binary logistic regression models attempted to predict naloxone stocking and dispensing, respectively.

RESULTS

Over half (58.1%) of pharmacies stocked naloxone, yet 23.6% of pharmacists dispensed it. Most (72.5%) pharmacists believed the standing order would increase naloxone stocking, and 66.5% believed it would increase dispensing. Chain pharmacies were 3.2 times as likely to stock naloxone. Naloxone stocking was 1.6 times as likely in pharmacies with more than one full-time pharmacist. Pharmacies where pharmacists received naloxone continuing education in the past two years were 1.3 times as likely to stock naloxone. The attempted dispensing model yielded no improvement over the constant-only model.

CONCLUSIONS

Pharmacies with larger capacity took advantage of the naloxone standing order. Predictors of pharmacist naloxone dispensing should continue to be explored to maximize naloxone access.

摘要

背景

尽管纳洛酮(一种用于逆转过量用药的药物)已经问世几十年,但通过药店获得该药的相关因素仍不清楚。有研究表明,政策和药剂师的信念可能会影响纳洛酮的可获得性。印第安纳州于 2015 年通过了一项纳洛酮常备处方法,以增加纳洛酮的可获得性。

目的

确定在全州范围内实施纳洛酮常备处方后,社区药店储备和配药纳洛酮的相关因素。

方法

在实施纳洛酮常备处方后,于 2016 年对印第安纳州社区药剂师进行了横断面普查。测量了社区、药店和药剂师的特征,以及药剂师对纳洛酮配药、获取和对常备处方的看法。采用修正泊松和二项逻辑回归模型分别尝试预测纳洛酮的储备和配药情况。

结果

超过一半(58.1%)的药店储备了纳洛酮,但只有 23.6%的药剂师配药。大多数(72.5%)药剂师认为常备处方会增加纳洛酮的储备,66.5%的药剂师认为会增加配药。连锁药店储备纳洛酮的可能性是其他药店的 3.2 倍。拥有多名全职药剂师的药店储备纳洛酮的可能性是其他药店的 1.6 倍。在过去两年中接受过纳洛酮继续教育的药店储备纳洛酮的可能性是其他药店的 1.3 倍。尝试的配药模型并未优于常数模型。

结论

具有较大储备能力的药店利用了纳洛酮常备处方。应继续探索药剂师配药纳洛酮的预测因素,以最大限度地增加纳洛酮的可获得性。